<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04389268</url>
  </required_header>
  <id_info>
    <org_study_id>Mansoura University HCV</org_study_id>
    <nct_id>NCT04389268</nct_id>
  </id_info>
  <brief_title>P300 in Early Cognitive Impairment in Hepatitis C Virus</brief_title>
  <official_title>Predictive Value of P300 Event-related Potential Component in Early Cognitive Impairment in Patients With Uncomplicated Newly Diagnosed Hepatitis C Virus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Approximately 50% of patients with hepatitis C have complaints of fatigue and cognitive
      deficits even before the development of significant hepatic impairment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Assessing the influence of HCV infection on the development of cognitive changes involves
      many challenges. The frequent presence of confounding factors such as illicit drug use,
      depression, and cirrhosis has the potential to produce cognitive impairment and therefore
      obscuring the role of HCV infection as a major actor in the development of cognitive
      impairment.

      The presence of brain dysfunction in patients with liver cirrhosis is well known. Zeegen et
      al. described in 1970, through the use of neuropsychological tests, the occurrence of
      cognitive changes involving mainly psychomotor speed, attention, and executive function in
      cirrhotics who did not have clinical criteria for hepatic encephalopathy. This condition is
      currently called minimal hepatic encephalopathy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Actual">February 1, 2019</completion_date>
  <primary_completion_date type="Actual">January 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Auditory P300-evoked brain potential</measure>
    <time_frame>24-72 hours</time_frame>
    <description>Auditory P300-evoked brain potential: an eventrelated potential of cognitive neurophysiological significance. It represents the brain response to certain sensory/cognitive stimuli by paying attention to the different stimulus among the stereotypical ones (the auditory oddball paradigm). It measures mainly the decision-making process (Polich and Kok, 1995).</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Hepatitis C</condition>
  <condition>Cognitive Impairment</condition>
  <arm_group>
    <arm_group_label>HCV patients</arm_group_label>
    <description>Patients with uncomplicated newly diagnosed hepatitis C virus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Age and sex matched with patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Visual Event-Related Potentials</intervention_name>
    <description>Auditory P300-evoked brain potential: an eventrelated potential of cognitive neurophysiological significance. It represents the brain response to certain sensory/cognitive stimuli by paying attention to the different stimulus among the stereotypical ones (the auditory oddball paradigm). It measures mainly the decision-making process (Polich and Kok, 1995).</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>HCV patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        100 participants consisted of 50 HCV patients and 50 healthy control, age and sex matched.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Newly diagnosed HCV infection

        Exclusion Criteria:

          -  Any neuropsychiatric disease that cause impaired cognition
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Esmael M Ahmed, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Prof of Neurology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mansoura University Hospital</name>
      <address>
        <city>Mansoura</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Latt NL. Update on the Management of Hepatitis C Virus Infection in the Setting of Chronic Kidney Disease and Kidney Transplantation. Gastroenterol Hepatol (N Y). 2018 Dec;14(12):687-705.</citation>
    <PMID>30804716</PMID>
  </reference>
  <reference>
    <citation>Louie KS, St Laurent S, Forssen UM, Mundy LM, Pimenta JM. The high comorbidity burden of the hepatitis C virus infected population in the United States. BMC Infect Dis. 2012 Apr 11;12:86. doi: 10.1186/1471-2334-12-86.</citation>
    <PMID>22494445</PMID>
  </reference>
  <reference>
    <citation>Barreira DP, Marinho RT, Bicho M, Fialho R, Ouakinin SRS. Psychosocial and Neurocognitive Factors Associated With Hepatitis C - Implications for Future Health and Wellbeing. Front Psychol. 2019 Jan 9;9:2666. doi: 10.3389/fpsyg.2018.02666. eCollection 2018. Review.</citation>
    <PMID>30687151</PMID>
  </reference>
  <reference>
    <citation>Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017 Mar;2(3):161-176. doi: 10.1016/S2468-1253(16)30181-9. Epub 2016 Dec 16. Review.</citation>
    <PMID>28404132</PMID>
  </reference>
  <reference>
    <citation>Waked I, Doss W, El-Sayed MH, Estes C, Razavi H, Shiha G, Yosry A, Esmat G. The current and future disease burden of chronic hepatitis C virus infection in Egypt. Arab J Gastroenterol. 2014 Jun;15(2):45-52. doi: 10.1016/j.ajg.2014.04.003. Epub 2014 Jun 6. Review.</citation>
    <PMID>25097045</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 12, 2020</study_first_submitted>
  <study_first_submitted_qc>May 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2020</study_first_posted>
  <last_update_submitted>May 12, 2020</last_update_submitted>
  <last_update_submitted_qc>May 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University Hospital</investigator_affiliation>
    <investigator_full_name>Ahmed Esmael</investigator_full_name>
    <investigator_title>Assistant Prof of Neurology</investigator_title>
  </responsible_party>
  <keyword>Hepatitis C, Cognitive Impairment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

